PLVAP and neoplasm: Patients with a high estimated fraction (>90th percentile) of either tumor-infiltrating CD8+ T cells or plasmalemma vesicle associated protein (PLVAP)+ endothelial cells were separately present in the scatter plot, suggesting mutual exclusivity of the two cell types concerning clinical outcome in the ccRCC environment.